Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Mitozantrone and methotrexate chemotherapy with and without mitomycin C in the treatment of advanced breast cancer: a randomised clinical trialR C Stein, M Bower, M Law, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 1, 1994
The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneityA M Moody, W P Mayles, J M Bliss, et al.
BMJ (Clinical Research Ed.)|March 14, 1992
Adjuvant psychological therapy for patients with cancer: a prospective randomised trialS Greer, S Moorey, J D Baruch, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 27, 2008
Evaluation of a method for grading late photographic change in breast appearance after radiotherapy for early breast cancerJ S Haviland, A Ashton, B Broad, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Randomised trial of epirubicin versus fluorouracil in advanced gastric cancer. An International Collaborative Cancer Group (ICCG) studyR C Coombes, C E Chilvers, D Amadori, et al.
The British Journal of Surgery|December 3, 2014
Learning from the QUEST multicentre feasibility randomization trials in breast reconstruction after mastectomyZ E Winters, M Emson, C Griffin, et al.
Contemporary Clinical Trials Communications|December 3, 2019
Biomarker-guided trials: Challenges in practiceM Antoniou, R Kolamunnage-Dona, J Wason, et al.
European Journal of Cancer (Oxford, England : 1990)|April 30, 2016
Epirubicin dose and sequential hormonal therapy-Mature results of the HMFEC randomised phase III trial in premenopausal patients with node positive early breast cancerR C Coombes, L S Kilburn, N Tubiana-Mathieu, et al.
International Journal of Cancer|August 9, 1995
Risk of cutaneous melanoma associated with a family history of the disease. The International Melanoma Analysis Group (IMAGE)D Ford, J M Bliss, A J Swerdlow, et al.
Pageof 7